UK Markets closed

Allied Healthcare Products, Inc. (AHPI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.6200-0.0100 (-0.61%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -4.41
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 316.4100
52-week low 31.5500
50-day moving average 32.0802
200-day moving average 34.0346

Share statistics

Avg vol (3-month) 360.53k
Avg vol (10-day) 343.37k
Shares outstanding 54.01M
Implied shares outstanding 6N/A
Float 83.51M
% held by insiders 114.55%
% held by institutions 18.95%
Shares short (28 Apr 2022) 459.31k
Short ratio (28 Apr 2022) 40.7
Short % of float (28 Apr 2022) 41.60%
Short % of shares outstanding (28 Apr 2022) 41.48%
Shares short (prior month 30 Mar 2022) 4137.59k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Dec 2016
Ex-dividend date 425 Jun 1996
Last split factor 21:2
Last split date 306 Dec 2016

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin -3.45%
Operating margin (ttm)-14.77%

Management effectiveness

Return on assets (ttm)-14.97%
Return on equity (ttm)-11.26%

Income statement

Revenue (ttm)29.15M
Revenue per share (ttm)7.26
Quarterly revenue growth (yoy)-38.70%
Gross profit (ttm)7.11M
EBITDA -3.82M
Net income avi to common (ttm)-1.01M
Diluted EPS (ttm)0.2110
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)183.04k
Total cash per share (mrq)0.05
Total debt (mrq)3.37M
Total debt/equity (mrq)39.97
Current ratio (mrq)1.59
Book value per share (mrq)2.39

Cash flow statement

Operating cash flow (ttm)-2.2M
Levered free cash flow (ttm)-1.66M